Literature DB >> 26989395

Crosstalk of Various Biomarkers That Might Provide Prompt Identification of Acute or Chronic Cardiorenal Syndromes.

Danijela Tasić1, Sonja Radenkovic2, Dijana Stojanovic3, Maja Milojkovic3, Miodrag Stojanovic4, Marina Deljanin Ilic5, Gordana Kocic6.   

Abstract

INTRODUCTION: Pathophysiological interaction between the heart and kidneys represents the basis for clinical entities called cardiorenal syndromes. The purpose of the study was to assess the relations between acute and chronic cardiorenal syndromes and biomarkers [advanced oxidation protein products, brain natriuretic peptide, malondialdehyde, xanthine oxidoreductase (XOD), xanthine oxidase, xanthine dehydrogenase, interleukin 8, cystatin C, plasminogen activator inhibitor-1, high-sensitive troponin T, C-reactive protein and glomerular filtration rate, measured by the Modification of Diet in Renal Disease (MDRD) formula], to hypothesize biomarkers that might provide a prompt identification of acute or chronic cardiorenal syndromes, and to distinguish acute versus chronic types of these syndromes.
METHODS: A total of 114 participants were enrolled in this study, i.e. 79 patients divided into subgroups of acute and chronic cardiorenal syndromes and 35 volunteers.
RESULTS: Nonadjusted odds ratio (OR) showed that there was a significant risk for acute cardiorenal syndrome with increased XOD activity (p = 0.037), elevated cystatin C concentration (p = 0.038) and MDRD (p = 0.028). Multivariable adjusted OR, on the other hand, revealed that only glomerular filtration rate measured by the MDRD formula had a significance for acute cardiorenal syndrome (p = 0.046). Nonadjusted OR showed a significant risk for chronic cardiorenal syndrome only in elderly (p = 0.002). Multivariable adjusted OR exhibited that age was the only risk factor for chronic cardiorenal syndrome (p = 0.012).
CONCLUSION: Cystatin C, glomerular filtration rate measured by the MDRD equation and XOD were independent risk factors for acute cardiorenal syndrome, while age remained an independent risk factor for chronic cardiorenal syndrome. When comparing ORs of evaluated parameters, the highest significance for acute cardiorenal syndrome was plasma concentration of cystatin C.

Entities:  

Keywords:  Cardiorenal syndromes; Cystatin C; Modification of Diet in Renal Disease formula; Xanthine oxidoreductase

Year:  2015        PMID: 26989395      PMCID: PMC4789923          DOI: 10.1159/000437309

Source DB:  PubMed          Journal:  Cardiorenal Med        ISSN: 1664-5502            Impact factor:   2.041


  23 in total

Review 1.  Plasminogen-activator inhibitor type 1 and coronary artery disease.

Authors:  H P Kohler; P J Grant
Journal:  N Engl J Med       Date:  2000-06-15       Impact factor: 91.245

Review 2.  Are advanced oxidation protein products potential uremic toxins?

Authors:  Véronique Witko-Sarsat; Valérie Gausson; Béatrice Descamps-Latscha
Journal:  Kidney Int Suppl       Date:  2003-05       Impact factor: 10.545

3.  Prognostic value of cystatin C on admission in heart failure with preserved ejection fraction.

Authors:  Francisco Javier Carrasco-Sánchez; Luis Galisteo-Almeda; Inmaculada Páez-Rubio; Francisco Javier Martínez-Marcos; Crescencio Camacho-Vázquez; Carlos Ruiz-Frutos; Emilio Pujol-De La Llave
Journal:  J Card Fail       Date:  2011-01       Impact factor: 5.712

4.  Cystatin C concentration as a risk factor for heart failure in older adults.

Authors:  Mark J Sarnak; Ronit Katz; Catherine O Stehman-Breen; Linda F Fried; Nancy Swords Jenny; Bruce M Psaty; Anne B Newman; David Siscovick; Michael G Shlipak
Journal:  Ann Intern Med       Date:  2005-04-05       Impact factor: 25.391

5.  Electron spin resonance characterization of vascular xanthine and NAD(P)H oxidase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation.

Authors:  Stephan Spiekermann; Ulf Landmesser; Sergey Dikalov; Martin Bredt; Graciela Gamez; Helma Tatge; Nina Reepschläger; Burkhard Hornig; Helmut Drexler; David G Harrison
Journal:  Circulation       Date:  2003-03-18       Impact factor: 29.690

Review 6.  Acute decompensated heart failure and the cardiorenal syndrome.

Authors:  Kelly V Liang; Amy W Williams; Eddie L Greene; Margaret M Redfield
Journal:  Crit Care Med       Date:  2008-01       Impact factor: 7.598

Review 7.  New and old markers of progression of diabetic nephropathy.

Authors:  G Jerums; E Premaratne; S Panagiotopoulos; S Clarke; D A Power; R J MacIsaac
Journal:  Diabetes Res Clin Pract       Date:  2008-10-19       Impact factor: 5.602

8.  Factors other than glomerular filtration rate affect serum cystatin C levels.

Authors:  Lesley A Stevens; Christopher H Schmid; Tom Greene; Liang Li; Gerald J Beck; Marshall M Joffe; Marc Froissart; John W Kusek; Yaping Lucy Zhang; Josef Coresh; Andrew S Levey
Journal:  Kidney Int       Date:  2008-12-31       Impact factor: 10.612

Review 9.  Pathophysiological and clinical relevance of circulating levels of cardiac natriuretic hormones: are they merely markers of cardiac disease?

Authors:  Aldo Clerico
Journal:  Clin Chem Lab Med       Date:  2002-08       Impact factor: 3.694

Review 10.  Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications.

Authors:  Cristine E Berry; Joshua M Hare
Journal:  J Physiol       Date:  2003-12-23       Impact factor: 5.182

View more
  1 in total

Review 1.  Cardiorenal Syndrome: New Pathways and Novel Biomarkers.

Authors:  Guido Gembillo; Luca Visconti; Maria Ausilia Giusti; Rossella Siligato; Alessia Gallo; Domenico Santoro; Alessandro Mattina
Journal:  Biomolecules       Date:  2021-10-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.